Home
Scholarly Works
491 NCIC CTG IND.177: Phase I study of AT7519M...
Conference

491 NCIC CTG IND.177: Phase I study of AT7519M given as a short infusion twice weekly

Authors

Hotte SJ; Chen EX; McIntosh L; Hirte HW; Turner S; Jarvi A; Squires MS; Seymour L

Volume

8

Publisher

Elsevier

Publication Date

November 1, 2010

DOI

10.1016/s1359-6349(10)72198-4

Conference proceedings

European Journal of Cancer Supplements

Issue

7

ISSN

1359-6349

Contact the Experts team